Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official [Yahoo! Finance Canada]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance Canada
Vaccine stocks slipped in late afternoon trade on Thursday after multiple reports indicated President-elect Donald Trump would name anti-vaccine activist Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Shares of Moderna ( MRNA ) fell over 5%, while Novavax ( NVAX ) stock lost over 7%. Pfizer ( PFE ) stock also slid more than 2.5%. Shares of both Moderna and Novavax are now down more than 30% over the past month. Moderna, Inc. (MRNA) Trump confirmed the nomination on Twitter after the market close. The stocks continued to fall slightly in after-hours trading. Trump said during a rally in late October that he would let Kennedy “go wild” on healthcare in the country, and vaccine stocks like Moderna and Novavax have been heading lower since. Thursday's news only furthered that move. “I'm gonna let him go wild on health. I'm gonna let him go wild on the food. I'm gonna let him go wild on medicines,” Trump said Kennedy told NPR in an interview on Nov.
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAXAccesswire
- How Technology Makes The CFO's Job More About Driving Value [Forbes]Forbes
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAXPR Newswire
- How Health, Innovation And A Bit Of Friction Help Pharmavite Succeed [Forbes]Forbes
- NVAX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Novavax, Inc.Accesswire
NVAX
Earnings
- 11/12/24 - Beat
NVAX
Sec Filings
- 11/20/24 - Form 8-K
- 11/13/24 - Form 4
- 11/13/24 - Form 3
- NVAX's page on the SEC website